首页> 外文期刊>ACS applied materials & interfaces >Design of Highly Potent Lipid-Functionalized Peptidomimetics for Efficient in Vivo siRNA Delivery
【24h】

Design of Highly Potent Lipid-Functionalized Peptidomimetics for Efficient in Vivo siRNA Delivery

机译:高强度脂质功能化拟肽的体内siRNA高效递送的设计。

获取原文
获取原文并翻译 | 示例
       

摘要

RNA interference (RNAi) is a highly efficient approach for gene silencing. Regulation of gene expression at post transcriptional level provides great potential for curing diseases caused by abnormal overexpression of disease-related genes. However, the application of RNAi in the clinic has been hindered by the lack of efficient and biocompatible delivery systems. Therefore, the development of a safe and tissue-targeted double-stranded interfering RNA (siRNA) carrier for clinical application is urgently needed. Here we report the discovery of a highly efficient liposomal siRNA delivery agent based on a novel peptidomimetic built from natural amino acids. Fine tuning of the composition of amino acids, the type of amide linkage in the peptidomimetic, as well as the formulation and the physicochemical parameters of the novel lipoplex resulted in a lipid nanoparticle (LNP) that efficiently encapsulates and carries siRNA to mouse liver. In vivo experiments showed that a single injection of unmodified siRNA complexed to one of the peptidomimetics at a clinically feasible dose induced significant RNAi in mouse liver, resulting in a 90% decrease in apolipoprotein B (ApoB) mRNA level, as well as a 60% decrease in serum ApoB protein level. Analysis of mouse serum by ELISA indicated that the novel peptidomimetic based lipoplex did not elevate the level of liver enzymes (ALT, AST) in the serum. Our novel peptidomimetic-based lipoplex demonstrated great potential for the development of a safe and efficient siRNA delivery agent for clinical applications.
机译:RNA干扰(RNAi)是一种高效的基因沉默方法。在转录后水平调节基因表达为治愈由疾病相关基因异常过表达引起的疾病提供了巨大潜力。但是,由于缺乏有效且生物相容的递送系统,RNAi在临床中的应用受到了阻碍。因此,迫切需要开发用于临床应用的安全且靶向组织的双链干扰RNA(siRNA)载体。在这里,我们报告了基于从天然氨基酸构建的新型拟肽的高效脂质体siRNA输送剂的发现。氨基酸组成,拟肽中酰胺键的类型以及新型脂质复合物的配方和理化参数的微调导致脂质纳米颗粒(LNP)有效地封装并将siRNA携带至小鼠肝脏。体内实验表明,以临床可行的剂量单次注射未修饰的siRNA与一种拟肽复合物,可在小鼠肝脏中诱导显着的RNAi,导致载脂蛋白B(ApoB)mRNA水平降低90%,以及60%降低血清ApoB蛋白水平。通过ELISA对小鼠血清的分析表明,新型基于拟肽的脂质复合物不会提高血清中肝酶(ALT,AST)的水平。我们基于肽模拟物的新型脂质复合物展示了开发用于临床应用的安全有效的siRNA递送剂的巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号